Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    ALVINA
Show Display Options
Rank Status Study
1 Completed Nutrition and Physical Activity in Patients With Cerebrovascular Disease
Condition: Cerebrovascular Disorders
Interventions: Dietary Supplement: Conventional diet +/- wine;   Dietary Supplement: Luxembourg variant of Mediterranean diet + physical activity +/- wine
2 Active, not recruiting A Multicenter Phase 2 Study of PCI-32765 (Ibrutinib) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion
Conditions: Chronic Lymphocytic Leukemia With 17p Deletion;   Small Lymphocytic Lymphoma With 17p Deletion
Intervention: Drug: PCI-32765
3 Recruiting Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery
Condition: Obesity
Intervention:
4 Not yet recruiting SmartCare: Innovations in Caregiving Interventions
Condition: Primary Malignant Brain Tumors
Interventions: Behavioral: CAU+ (Enhanced Care as Usual);   Behavioral: Beating the Blues;   Behavioral: SmartCare

Indicates status has not been verified in more than two years